Phosphodiesterase 5 inhibitors lower both portal and pulmonary pressure in portopulmonary hypertension: a case report

BACKGROUND: Portopulmonary hypertension (PPHTN) is a severe complication in liver cirrhosis. PDE5 inhibitors lower pulmonary arterial pressure (PAP) in PPHTN. However, their effect on portal hypertension has not yet been investigated. CASE PRESENTATION: A 55 year old male patient presented with PPHT...

Descripción completa

Detalles Bibliográficos
Autores principales: Bremer, Hinrich C, Kreisel, Wolfgang, Roecker, Kai, Dreher, Michael, Koenig, Daniel, Kurz-Schmieg, Anna Katharina, Blum, Hubert E, Roessle, Martin, Deibert, Peter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971060/
https://www.ncbi.nlm.nih.gov/pubmed/17623085
http://dx.doi.org/10.1186/1752-1947-1-46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971060/
https://www.ncbi.nlm.nih.gov/pubmed/17623085
http://dx.doi.org/10.1186/1752-1947-1-46

Ejemplares similares